These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25460083)

  • 1. Distinct kinetics of viral replication, T cell infiltration, and fibrosis in three phases of myocarditis following Theiler's virus infection.
    Sato F; Omura S; Kawai E; Martinez NE; Acharya MM; Reddy PC; Chaitanya GV; Alexander JS; Tsunoda I
    Cell Immunol; 2014; 292(1-2):85-93. PubMed ID: 25460083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theiler's Virus-Mediated Immunopathology in the CNS and Heart: Roles of Organ-Specific Cytokine and Lymphatic Responses.
    Omura S; Kawai E; Sato F; Martinez NE; Minagar A; Al-Kofahi M; Yun JW; Cvek U; Trutschl M; Alexander JS; Tsunoda I
    Front Immunol; 2018; 9():2870. PubMed ID: 30619258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facets of Theiler's Murine Encephalomyelitis Virus-Induced Diseases: An Update.
    Gerhauser I; Hansmann F; Ciurkiewicz M; Löscher W; Beineke A
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ-specific protective role of NKT cells in virus-induced inflammatory demyelination and myocarditis depends on mouse strain.
    Kawai E; Sato F; Omura S; Martinez NE; Reddy PC; Taniguchi M; Tsunoda I
    J Neuroimmunol; 2015 Jan; 278():174-84. PubMed ID: 25434008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theiler's virus infection chronically alters seizure susceptibility.
    Stewart KA; Wilcox KS; Fujinami RS; White HS
    Epilepsia; 2010 Aug; 51(8):1418-28. PubMed ID: 20002148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis.
    Omura S; Kawai E; Sato F; Martinez NE; Chaitanya GV; Rollyson PA; Cvek U; Trutschl M; Alexander JS; Tsunoda I
    Circ Cardiovasc Genet; 2014 Aug; 7(4):444-54. PubMed ID: 25031303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice.
    Gerety SJ; Karpus WJ; Cubbon AR; Goswami RG; Rundell MK; Peterson JD; Miller SD
    J Immunol; 1994 Jan; 152(2):908-18. PubMed ID: 7904291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential virus replication, cytokine production, and antigen-presenting function by microglia from susceptible and resistant mice infected with Theiler's virus.
    Jin YH; Mohindru M; Kang MH; Fuller AC; Kang B; Gallo D; Kim BS
    J Virol; 2007 Nov; 81(21):11690-702. PubMed ID: 17715222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler's virus is located within VP1(233-244).
    Yauch RL; Kim BS
    J Immunol; 1994 Nov; 153(10):4508-19. PubMed ID: 7525707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theiler's murine encephalomyelitis virus-induced cardiac and skeletal muscle disease.
    Gómez RM; Rinehart JE; Wollmann R; Roos RP
    J Virol; 1996 Dec; 70(12):8926-33. PubMed ID: 8971022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis.
    Tsunoda I; Sato F; Omura S; Fujita M; Sakiyama N; Park AM
    Clin Exp Neuroimmunol; 2016 Nov; 7(4):330-345. PubMed ID: 28603559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy.
    DePaula-Silva AB; Hanak TJ; Libbey JE; Fujinami RS
    J Neuroimmunol; 2017 Jul; 308():30-42. PubMed ID: 28237622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice.
    Chang JR; Zaczynska E; Katsetos CD; Platsoucas CD; Oleszak EL
    Virology; 2000 Dec; 278(2):346-60. PubMed ID: 11118358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The level of viral infection of antigen-presenting cells correlates with the level of development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Jin YH; Kang HS; Hou W; Meng L; Kim BS
    J Virol; 2015 Feb; 89(3):1867-78. PubMed ID: 25428872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of live virus protects susceptible mice from developing Theiler's virus-induced demyelinating disease.
    Kang BS; Yahikozawa H; Koh CS; Kim BS
    Virology; 2007 Sep; 366(1):185-96. PubMed ID: 17507073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
    Gerety SJ; Rundell MK; Dal Canto MC; Miller SD
    J Immunol; 1994 Jan; 152(2):919-29. PubMed ID: 7506740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 production by brain tissue and cultured astrocytes infected with Theiler's murine encephalomyelitis virus.
    Rubio N; Sierra A
    Glia; 1993 Sep; 9(1):41-7. PubMed ID: 8244530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. IV. Identification of an immunodominant T cell determinant on the N-terminal end of the VP2 capsid protein in susceptible SJL/J mice.
    Gerety SJ; Clatch RJ; Lipton HL; Goswami RG; Rundell MK; Miller SD
    J Immunol; 1991 Apr; 146(7):2401-8. PubMed ID: 1706400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparate expression of IL-12 by SJL/J and B10.S macrophages during Theiler's virus infection is associated with activity of TLR7 and mitogen-activated protein kinases.
    Petro TM
    Microbes Infect; 2005 Feb; 7(2):224-32. PubMed ID: 15777634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of Theiler's virus requires NF-kappa B-activation: higher viral replication and spreading in astrocytes from susceptible mice.
    Kang MH; So EY; Park H; Kim BS
    Glia; 2008 Jul; 56(9):942-53. PubMed ID: 18383344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.